Can CRISPR Make CAR T Safer and More Scalable?
Combining CRISPR/Cas9 with CAR T aims to let patients’ T cells be reprogrammed in vivo, potentially lowering cost and expanding use to solid tumors and autoimmune disease. Medscape News Global
Read the full articleYou might also wanna read
Resetting autoimmune disease with CAR cell therapies
Explore the potential of CAR T cells in autoimmune diseases: a novel way to target B cells, reset immunity, and meet clinical gaps! PMID:421
CAR T-cell therapy bolstered by stiffening up cancer cells first
CAR T-cell therapy has been hugely successful in treating certain types of tumours, and stiffening up cancer cells beforehand could make it
Triple Cytokine Scaffold Aims to Extend CAR T-Cell Persistence Against HIV
A new approach aims to use CAR T cells to last longer in the fight against HIV.
medscape.com·14d ago
A revolutionary cancer treatment could transform autoimmune disease
Researchers are testing CAR T cell therapy as a way to reset the immune system in lupus, Graves’ disease and other conditions where the body
AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
An AI-guided framework integrating high-resolution cellular atlases, public knowledge databases, and large language models enables a modular
OHSU advances massive leap in medical science with cellular therapies
Patients are benefiting from CAR-T to treat neurodegenerative diseases, cancer, lupus and other autoimmune conditions.
Comments
Sign in to join the conversation.
No comments yet. Be the first.